By The Online Investor Staff, updated Thu., Feb. 11, 1:21 AM
Slide #1. Editas Medicine, Inc. — Initial Public Offering
||Editas Medicine, Inc.
|Price Per Share:
||Editas Medicine, Inc., a leading genome editing company, today announced the pricing of its initial public offering of 5,900,000 shares of common stock at a public offering price of $16.00 per share, before underwriting discounts and commissions. All of the shares are being offered by Editas Medicine. In addition, the company has granted the underwriters a 30-day option to purchase up to an additional 885,000 shares of common stock from Editas Medicine at the public offering price, less underwriting discounts and commissions, to cover over-allotments, if any. The company's common stock has been approved for listing on the NASDAQ Global Select Market and is expected to begin trading on Wednesday, February 3, 2016 under the ticker symbol "EDIT."
IPOs: Editas Medicine, Inc.
List of IPOs in this Slideshow:
Company Ticker IPO Date
Noble Midstream Partners LP NBLX
Xtera Communications, Inc. XCOM
Mesoblast Limited MESO
Mimecast Limited MIME
Match Group, Inc. MTCH
Square, Inc. SQ
Duluth Holdings Inc. DLTH
Kitov Pharmaceuticals Holdings Ltd. KTOV
Yirendai Ltd. YRD
China Customer Relations Centers, Inc. CCRC
Advanced Disposal Services, Inc. ADSW
BeiGene, Ltd. BGNE
Editas Medicine, Inc. EDIT
February 11, 2016 1:21 AM Eastern